Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Supernus Pharmaceuticals Prices Its IPO In The Range Of $12-$14 Per Share

Supernus Pharmaceuticals Wednesday announced that it has filed Form S-1 with the Securities and Exchange Commission or the SEC revealing the pricing of its initial public offering for 5,769,000 shares of common stock.

The company revealed that it anticipates to price the initial public offering to be between $12.00 and $14.00 per share of common stock.

The company further added that it has granted the underwriters an option to purchase up to 865,350 additional shares of common stock to cover over-allotments.

The company stated that itsd shares would be listed on the Nasdaq Global Market under the symbol "SUPN."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Businessman David Perdue narrowly defeated eleven-term Congressman Jack Kingston, R-Ga., in a runoff for the Republican Senate nomination in Georgia on Tuesday. With all precincts reporting, unofficial results show Perdue with a slim 50.9 percent to 49.1 percent lead over Kingston. Stocks are turning in a lackluster performance in early trading on Wednesday after moving mostly higher over the course of the previous session. The major averages are showing only modest moves, although the S&P 500 did manage to reach a new record intraday high. Bank of England Governor Mark Carney said on Wednesday that interest rate will have to start rising to maintain price stability as the economy normalizes. "As the economy normalizes, Bank Rate will need to start to rise in order to achieve the inflation target," Carney said in a speech in Glasgow, Scotland.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.